Between a rock and a hard place: anticoagulation management for ECMO

Area of Science:

• Critical care medicine
• Hematology
• Cardiovascular medicine

Background:

• Anticoagulation is crucial for extracorporeal membrane oxygenation (ECMO) but presents challenges.
• Unfractionated heparin is common but has drawbacks like protein binding and heparin-induced thrombocytopenia.
• Direct thrombin inhibitors are alternatives but monitoring is difficult.

Purpose of the Study:

• To review current anticoagulation strategies in ECMO.
• To highlight challenges in monitoring anticoagulation.
• To emphasize the need for individualized anticoagulation and future research.

Main Methods:

• Review of current literature and clinical practices regarding ECMO anticoagulation.
• Discussion of heparin and direct thrombin inhibitor use and monitoring.
• Analysis of trends in low-dose anticoagulation and associated risks.

Main Results:

• Unfractionated heparin remains standard despite limitations.
• Monitoring direct thrombin inhibitors is challenging.
• Low-dose anticoagulation trends are noted, but evidence for individualization is lacking.

Conclusions:

• Individualized anticoagulation, transfusion, and bleeding management require prospective data.
• Empirical anticoagulation based solely on labs is insufficient.
• Collaboration and further research are vital for safer and more effective ECMO therapy.